H00003292-M03

antibody from Novus Biologicals

Targeting: HSD17B1 EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

H00003292-M03

Provider

Novus Biologicals

Proper citation

Novus Cat#H00003292-M03, RRID:AB_2119656

Product name

Mouse Monoclonal 17 beta-HSD1/HSD17B1 Antibody

Antibody type

Monoclonal

Antigen

HSD17B1 (NP_000404, 189 a.a. ~ 286 a.a) partial recombinant protein with GST tag.VHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVF

Description

Antibody reactive against cell lysate and recombinant protein for Western Blot. Has also been used for immunohistochemistry (paraffin) and ELISA.

Reactivity

Human

Host

Mouse

Isotype

IgG

Vial size

0.05 mg

Storage

Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.

References

Submitted references

Steroidogenesis in ovarian-like mesenchymal stroma of hepatic and pancreatic mucinous cystic neoplasms.

Kumata H, Murakami K, Ishida K, Miyagi S, Arakawa A, Inayama Y, Kinowaki K, Ochiai A, Kojima M, Higashi M, Moritani S, Kuwahara K, Nakatani Y, Kajiura D, Tamura G, Kijima H, Yamakawa M, Shiraishi T, Inadome Y, Murakami K, Suzuki H, Sawai T, Unno M, Kamei T, Sasano H
Hepatology research : the official journal of the Japan Society of Hepatology 2018 Nov;48(12):989-999

---

The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer.

McNamara KM, Oguro S, Omata F, Kikuchi K, Guestini F, Suzuki K, Yang Y, Abe E, Hirakawa H, Brown KA, Takanori I, Ohuchi N, Sasano H
Breast cancer research and treatment 2017 Jan;161(2):213-227

---

The role of estrogen-metabolizing enzymes and estrogen receptors in human epidermis.

Inoue T, Miki Y, Abe K, Hatori M, Hosaka M, Kariya Y, Kakuo S, Fujimura T, Hachiya A, Aiba S, Sasano H
Molecular and cellular endocrinology 2011 Sep 15;344(1-2):35-40

---

Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.

Chanplakorn N, Chanplakorn P, Suzuki T, Ono K, Chan MS, Miki Y, Saji S, Ueno T, Toi M, Sasano H
Breast cancer research and treatment 2010 Apr;120(3):639-48